Skip to main navigation Skip to search Skip to main content

Nanoparticles Dysregulate the Human Placental Secretome with Consequences on Angiogenesis and Vascularization

  • Battuja Dugershaw-Kurzer
  • , Jonas Bossart
  • , Marija Buljan
  • , Yvette Hannig
  • , Sarah Zehnder
  • , Govind Gupta
  • , Vera M. Kissling
  • , Patrycja Nowak-Sliwinska
  • , Judy R. van Beijnum
  • , Arjan W. Griffioen
  • , Stefan Masjosthusmann
  • , Etta Zühr
  • , Ellen Fritsche
  • , René Hornung
  • , Thomas Rduch
  • , Tina Buerki-Thurnherr*
  • *Corresponding author for this work
  • Swiss Federal Laboratories for Materials Science and Technology (Empa)
  • Swiss Federal Institute of Technology Zurich
  • Swiss Institute of Bioinformatics
  • Institute of Pharmaceutical Sciences of Western Switzerland
  • University of Geneva
  • Vrije Universiteit Amsterdam
  • Leibniz Research Institute for Environmental Medicine
  • Heinrich Heine University Düsseldorf
  • DNTOX GmbH
  • Cantonal Hospital St. Gallen

Research output: Contribution to journalArticleAcademicpeer-review

24 Downloads (Pure)

Abstract

Exposure to nanoparticles (NPs) in pregnancy is increasingly linked to adverse effects on embryo-fetal development and health later in life. However, the developmental toxicity mechanisms of NPs are largely unknown, in particular potential effects on the placental secretome, which orchestrates many developmental processes pivotal for pregnancy success. This study demonstrates extensive material- and pregnancy stage-specific deregulation of placental signaling from a single exposure of human placental explants to physiologically relevant concentrations of engineered (silica (SiO2) and titanium dioxide (TiO2) NPs) and environmental NPs (diesel exhaust particles, DEPs). This includes a multitude of secreted inflammatory, vascular, and endocrine placental factors as well as extracellular vesicle (EV)-associated proteins. Moreover, conditioned media (CM) from NP-exposed explants induce pronounced anti-angiogenic and anti-vasculogenic effects, while early neurodevelopmental processes are only marginally affected. These findings underscore the potential of metal oxide NPs and DEPs for widespread interference with the placental secretome and identify vascular morphogenesis as a sensitive outcome for the indirect developmental toxicity of different NPs. Overall, this work has profound implications for the future safety assessment of NPs for industrial, commercial, or medical applications in pregnancy, which should consider placenta-mediated toxicity by holistic secretomics approaches to ensure the development of safe nanotechnologies.
Original languageEnglish
Article number2401060
JournalAdvanced Science
Volume11
Issue number28
DOIs
Publication statusPublished - 24 Jul 2024

Keywords

  • angiogenesis
  • developmental toxicity
  • nanoparticles
  • placenta
  • secretome

Fingerprint

Dive into the research topics of 'Nanoparticles Dysregulate the Human Placental Secretome with Consequences on Angiogenesis and Vascularization'. Together they form a unique fingerprint.

Cite this